Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MustGrow Biologics Corp V.MGRO

Alternate Symbol(s):  MGROF

MustGrow Biologics Corp. is a Canada-based agricultural biotechnology company. The Company is engaged in developing natural biological products derived from mustard seed to support sustainable farming. Its solutions provide alternatives to banned or restricted synthetic chemicals and fertilizers, promoting organic farming and soil health improvement. The Company develops mustard-based organic... see more

TSXV:MGRO - Post Discussion

MustGrow Biologics Corp > MustGrow Biologics Closes Financing At Final Figure Of $7.1M
View:
Post by AwareInvestor on Oct 07, 2021 7:53am

MustGrow Biologics Closes Financing At Final Figure Of $7.1M

MustGrow Biologics this morning closed off its previously announced private placement financing. The company managed to raise significant funds under the raise, bringing in total gross proceeds of $7.1 million.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities